Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped trial is not feasible (very low event rates, no available risk predictor with acceptable predictive performance for discrimination of high-risk patients)

Conditions

Myocardial Infarction
Sudden Cardiac Death

Interventions

DRUG: Optimal Medical Therapy (OMT)
DEVICE: Implantable cardioverter-defibrillator (ICD)

Sponsor

Helios Health Institute GmbH